DYRK1B and familial pancreatic carcinoma: In similar studies inhibiting DYRK1A [157] with Harmine improved the efficacy of Imatinib in clearing gastrointestinal cancer in mice [158], while DYRK1B inhibition combined with Gemcitabine was shown to improve pancreatic cancer cell killing in vitro [159].